Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study on Pemetrexed in Advanced and/or Recurrent Cervical Cancer
2006-005626-24Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pemetrexed in Cervical Cancer (CC), sponsored by Policlinico Gemelli. Primary endpoint: Tumor response rate. Started Jun 2007; status: completed.
02
Drugs
pemetrexed
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on 2006-005626-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005626-24.